PRAKASH MERAI: Open Payments
NPI 1851488498 · AUGUSTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,605 in 83 payments from 11 companies in 2025. Trend: 2023 $2,405 · 2024 $2,530 · 2025 $2,605
Food & beverage: $2,511Education: $95
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 26 | $716 |
| E.R. Squibb & Sons, L.L.C. | 9 | $385 |
| Alkermes, Inc. | 12 | $309 |
| Otsuka America Pharmaceutical, Inc. | 7 | $247 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $187 |
| Janssen Pharmaceuticals, Inc | 8 | $181 |
| Axsome Therapeutics, Inc. | 3 | $170 |
| Vanda Pharmaceuticals Inc. | 2 | $152 |
| Lundbeck LLC | 5 | $119 |
| Neurocrine BioSciences, Inc. | 5 | $95 |
Products named: COBENFY, AUSTEDO XR, ARISTADA, UZEDY, ABILIFY ASIMTUFII, CAPLYTA, INVEGA SUSTENNA, Auvelity.
Industry payments across GA — which companies pay providers there.
